Figure 2From: The Multi-target Effects of CNI-1493: Convergence of Antiamylodogenic and Antiinflammatory Properties in Animal Models of Alzheimer’s DiseaseC1213 in vitro is considerably less toxic than CNI-1493. Primary microglia (A + B) and primary neurons (C + D) were treated with the indicated concentrations of CNI-1493 or Compound-1213 for 24 h. Cell proliferation (A + C) and cell death (B + D) were analyzed by MTT and LDH assay, respectively. * P < 0.05, ** P < 0.01, *** P < 0.001.Back to article page